|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/435 | |
| A61K 38/16 | |||
| A61P 35/00 |
| (11) | Patento numeris | 1976529 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07762831.1 |
| Europos patento paraiškos padavimo data | 2007-01-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-10-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-12-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/001365 |
| Data | 2007-01-19 |
| (87) | Numeris | WO 2007/089445 |
| Data | 2007-08-09 |
| (30) | Numeris | Data | Šalis |
| 762493 P | 2006-01-27 | US |
| (72) |
OLINER, Jonathan, US
KENDALL, Richard, US
KUMAR, Rakesh, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive M/S 28-2-C, Thousand Oaks, CA 91320-1799,
US
|
| (54) | ANG2 AND VEGF INHIBITOR COMBINATIONS |
| ANG2 AND VEGF INHIBITOR COMBINATIONS |